Multiple endocrine neoplasia type 1–associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example-Reference-Cited by-同舟云学术

Multiple endocrine neoplasia type 1–associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example

Published:2009-02 Issue:2 Volume:40 Page:270-278
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Scheithauer Bernd W.,Kovacs Kalman,Nose Vania,Lombardero Matilde,Osamura Yoshiyuki R.,Lloyd Ricardo V.,Horvath Eva,Pagenstecher Axel,Bohl Jürgen E.,Tews Dominique S.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference47 articles.

1. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health;Brucker-Davis;J Clin Endocrinol Metab,1999

2. Thyrotropin-secreting pituitary tumors;Beck-Peccoz;Endocr Rev,1996

3. Surgical treatment of thyrotropin-secreting pituitary adenomas;McCutcheon;J Neurosurg,1990

4. Pituitary carcinoma: a clinicopathologic study of 15 cases;Pernicone;Cancer,1997

5. Thyrotropin-secreting pituitary carcinoma;Mixson;J Clin Endocrinol Metab,1993

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors;Brain Pathology;2024-09

2. French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1;Annales d'Endocrinologie;2023-09

3. Growth Hormone Excess: Implications and Management;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-05

4. Molecular and Clinical Spectrum of Primary Hyperparathyroidism;Endocrine Reviews;2023-03-24

5. Outcome and prognostic factors for pituitary carcinomas: lessons from a systematic review;Endocrine-Related Cancer;2023-02-27